Abstract Submission Guidelines
We welcome abstracts from researchers, clinicians, and students alike. Every submission is reviewed by our scientific committee for relevance, originality, clarity, and scientific merit — here's what to keep in mind while preparing yours.
Abstract Requirements
You can view the abstract submission guidelines below for the details on the format, structure, and key requirements. For reference, download the sample abstract format.
- Title:Keep the title concise, informative, and relevant to the research.
- Word Limit: The abstract word count should be up to 300 words.
- Structure: The abstract should briefly include the background, objectives, methodology, key results/findings, and conclusion (Recommended).
- Authors: List the full names of authors, along with their institutional affiliations and email addresses. Clearly indicate the presenting author.
- Format: Submit as DOC, DOCX, or PDF (maximum 10 MB) with clear and consistent formatting.
- Originality: Abstracts must present original work and be free from plagiarism.
- Language: Abstracts must be submitted in English.
Submit your abstract
Fields marked * are required. You'll receive the review outcome by email.
Abstract Submission Deadlines
| First Phase Early Bird | February 8, 2026 |
| Second Phase Mid Term | February 25, 2026 |
| Final Phase Final Call | March 13, 2026 |
Submission Process
Abstracts should be submitted through the designated conference submission platform before the stated deadline. Each submission will be assigned for review by the conference committee.
Review and Acceptance
All abstracts will undergo a review process. Authors will be notified of the acceptance or rejection of their abstracts within 5 business days by the conference committee.
Important Note
Authors of accepted abstracts must register for the conference within the specified registration period to be included in the final conference programme/proceedings. The presenting author is expected to attend the conference and present the accepted work.
Scientific Sessions
- Neuroscience and Neurology
- Psychiatry
- Neuroimmunology
- Child and Adolescent Psychiatry
- Psychology and Mental Health
- Paediatric Neurology
- Neuropharmacology and Neuroendocrinology
- Neuroinfections and Neuroinflammation
- Alzheimer Disease, Ageing and Dementia
- Neuro-Oncology
- Stroke and Trauma
- Neurosurgery
- Brain and Neurological Disorders
- Neuroimaging and pathology
- Neurotherapeutics, Diagnostics and Case studies
- Neurological Complications of COVID_19
- Legal and Ethical Issues in Clinical Research
Frequently Asked Questions
Authors can submit their abstracts through the online abstract submission portal available on the conference website or via the official conference email.
Abstracts related to the conference theme and scientific sessions are welcome. Multidisciplinary and innovative research contributions are highly encouraged.
The submission deadline will be informed through email upon request. Participants are encouraged to submit early to allow sufficient time for review and confirmation.
Yes, authors are requested to follow the abstract guidelines provided on the website, including title, author details, biography, objectives, results, and conclusion.
Once the review process is completed, the acceptance notification will be sent to the corresponding author via email.
Minor revisions may be accepted before the final submission deadline. Authors should contact the conference manager for assistance regarding modifications through email.
Previously presented or published work may be considered depending on the conference policies.
Accepted abstracts will be included in the conference proceedings, abstract book, subject to editorial policies.
Yes, students, research scholars, and early-career investigators are strongly encouraged to submit their research work.
Yes, at least one author (if not for all) of each accepted abstract is generally required to complete registration to confirm inclusion in the conference program.
Quick Links
Explore More
Past Conferences
Past Webinars
General Enquiry
Finance Enquiry
Contact Number
- (+1) 918 942 1748